Crown Castle Inc (CCI) concluded trading on Thursday at a closing price of $100.75, with 3.69 million shares of worth about $371.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.57% during that period and on April 24, 2025 the price saw a loss of about -1.50%. Currently the company’s common shares owned by public are about 435.00M shares, out of which, 434.26M shares are available for trading.
Stock saw a price change of -0.49% in past 5 days and over the past one month there was a price change of 0.30%. Year-to-date (YTD), CCI shares are showing a performance of 11.01% which increased to 5.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $84.20 but also hit the highest price of $120.92 during that period. The average intraday trading volume for Crown Castle Inc shares is 3.41 million. The stock is currently trading -0.35% below its 20-day simple moving average (SMA20), while that difference is up 2.53% for SMA50 and it goes to -2.06% lower than SMA200.
Crown Castle Inc (NYSE: CCI) currently have 435.00M outstanding shares and institutions hold larger chunk of about 93.95% of that.
The stock has a current market capitalization of $43.87B and its 3Y-monthly beta is at 0.93. It has posted earnings per share of -$8.97 in the same period. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCI, volatility over the week remained 2.74% while standing at 3.39% over the month.
Stock’s fiscal year EPS is expected to rise by 111.50% while it is estimated to increase by 156.86% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on March 20, 2025 offering a Neutral rating for the stock and assigned a target price of $110 to it. On March 17, 2025, Wells Fargo Upgrade their recommendations, while on March 14, 2025, UBS Upgrade their ratings for the stock with a price target of $118. Stock get a Strong buy rating from Raymond James on March 14, 2025.
